Inventor · disambiguated record
Matthew Duncton
Also filed as: DUNCTON MATTHEW · DUNCTON MATTHEW A J · DUNCTON MATTHEW ALEXANDER JAME · DUNCTON MATTHEW ALEXANDER JAMES
30 granted patents·46 pending applications·104 citations·filing 1999–2025
95Inventor score
Files withTERRAN BIOSCIENCES INC31NFLECTION THERAPEUTICS INC9ARIXA PHARMACEUTICALS INC8RENOVIS INC4VERNALIS RES LTD4
Top patents by PatentIndex Score
76 records- 0197US10085999B1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2018·Granted Oct 2, 2018·16 cites·30 claims
- 0295US11161845B2Pyrrolopyridine-aniline compounds for treatment of dermal disordersNFLECTION THERAPEUTICS INC·Filed 2018·Granted Nov 2, 2021·9 cites·28 claims
- 0392US12065439B2Pyrrolopyridine-aniline compounds for treatment of dermal disordersNFLECTION THERAPEUTICS INC·Filed 2021·Granted Aug 20, 2024·2 cites·33 claims
- 0490US10988483B2Fused heteroaromatic-aniline compounds for treatment of dermal disordersNFLECTION THERAPEUTICS INC·Filed 2018·Granted Apr 27, 2021·5 cites·34 claims
- 0587US2024415847A1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0686US12428418B2Pyrrolopyridine-aniline compounds for treatment of dermal disordersNFLECTION THERAPEUTICS INC·Filed 2024·Granted Sep 30, 2025·0 cites·4 claims
- 0785US2025388580A1Pyrrolopyridine-aniline compounds for treatment of dermal disordersNFLECTION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0884US7576099B2Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the sameRENOVIS INC·Filed 2006·Granted Aug 18, 2009·5 cites·24 claims
- 0982US10722521B2Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·1 cites·24 claims
- 1082US2023201218A1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1179US12435036B2Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-n,n-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2024·Granted Oct 7, 2025·0 cites·14 claims
- 1279US7312233B2Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the sameRENOVIS INC·Filed 2006·Granted Dec 25, 2007·3 cites·23 claims
- 1377US11572344B2Cyanoaryl-aniline compounds for treatment of dermal disordersNFLECTION THERAPEUTICS INC·Filed 2019·Granted Feb 7, 2023·1 cites·21 claims
- 1475US12319652B2Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2023·Granted Jun 3, 2025·0 cites·30 claims
- 1575US12234216B2Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2022·Granted Feb 25, 2025·0 cites·14 claims
- 1675US2023202998A1Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1773US12269818B2Analogs of xanomelineTERRAN BIOSCIENCES INC·Filed 2024·Granted Apr 8, 2025·0 cites·42 claims
- 1872US6433175B1Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonistsVERNALIS RES LTD·Filed 1999·Granted Aug 13, 2002·32 cites·27 claims
- 1972US2024002337A1Salts and solid forms of (r)-1-(5-methoxy-1h-indol-1-yl)-n,n-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2072US2025011351A1Psilocybin and o-acetylpsilocin, salts and solid state forms thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2170US11866408B2N,N-dimethyltryptamine and related psychedelics and uses thereofTERRAN BIOSCIENCES INC·Filed 2023·Granted Jan 9, 2024·0 cites·28 claims
- 2270US11542271B2Fused heteroaromatic-aniline compounds for treatment of dermal disordersNFLECTION THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·0 cites·13 claims
- 2369US2024317783A1Processes of preparing psilocin and psilocybinTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2468US10500211B2Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2018·Granted Dec 10, 2019·0 cites·26 claims
- 2568US6800627B1Pirazino indole derivativesVERNALIS RES LTD·Filed 2000·Granted Oct 5, 2004·3 cites·18 claims
- 2668US6380238B1Indoline derivatives as 5-HT2B and or 5-HTC receptor ligandsVERNALIS RES LTD·Filed 1999·Granted Apr 30, 2002·27 cites·23 claims
- 2768US2020297733A1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2868US2023159456A1N-substituted indolesTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2968US2024116870A1N,n-dimethyltryptamine and related psychedelics and uses thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3068US2025066299A1Salts and solid forms of 4-hydroxy-n,n-diisopropyltryptamine hemi-glutarate and hemi-succinateTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3167US2023150965A1Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3267US2023257385A1Salt and solid forms of tabernanthalogTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3366US2025109130A1Isotopically enriched analogs of 2-bromo-lsd, lsd, ald-52, and 1p-lsdTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3466US2024099300A1Sulfonamide apyrase inhibitorsTEXAS CROP SCIENCE·Filed 2023·Application pending·0 cites
- 3566US2024400512A1Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamineTERRAN BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3666US2025034105A1Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereofTERRAN BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3765US2023181521A1Isotopically enriched analogs of 5,6-methylenedioxy-2-aminoindane (mdai)TERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3865US2024294488A1Isotopologes, salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3965US2023150936A1Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4064US12297171B2EP2 antagonist compoundsRESERVOIR NEUROSCIENCE INC·Filed 2023·Granted May 13, 2025·0 cites·17 claims
- 4164US12037357B2Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cellsDECIDUOUS THERAPEUTICS INC·Filed 2023·Granted Jul 16, 2024·0 cites·18 claims
- 4263US2024101510A1Apyrase inhibitorsTEXAS CROP SCIENCE·Filed 2023·Application pending·0 cites
- 4361US2023159544A1Azepino-indoles for the treatment of neurological and psychiatric disordersTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4461US2025091993A1Salts and solid forms of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amineTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 4560US2025195477A1Deuterated idazoxan and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 4660US2025136548A1Functionalized alkylaminesTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 4760US2025388583A1Compounds and method for pkmyt1 inhibitionENGINE BIOSCIENCES PTE LTD·Filed 2023·Application pending·0 cites
- 4859US12466818B2Thienyl-aniline compounds for treatment of dermal disordersNFLECTION THERAPEUTICS INC·Filed 2019·Granted Nov 11, 2025·0 cites·16 claims
- 4959US2025129054A1Prodrugs of 3,4-methylenedioxy-n-methcathinone and uses thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 5059US2025049748A1Analogs of 4-bromo-2,5-dimethoxyphenethylamineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →